Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Chinese biotech hamstrung by production issues

China's fast-developing biopharmaceutical industry is encountering a scale-up and production bottleneck.

This is a preview of subscription content, access via your institution

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Author information

Authors and Affiliations

Authors

Related links

Related links

Related links in Nature Research

Poor enforcement could jeopardize China's drug innovation policy

Handle with care

Lack of private financing hobbles emerging biotech regions

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Jia, H. Chinese biotech hamstrung by production issues. Nat Biotechnol 25, 147–148 (2007). https://doi.org/10.1038/nbt0207-147

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0207-147

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing